A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease

Table 4 HER2 status of primary and matched recurrent lesion by in-situ hybridization

The 2* cases which did not contain breast malignancy upon central review were excluded.

ISSN: 1471-2407